Lexicon Pharmaceuticals (LXRX) - News Mentions

Sign up to add (LXRX) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 0 0%
Gilead Sciences
Gilead Sciences
GILD		 0 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
Research Analysts Issue Forecasts for LXRX FY2024 Earnings
November 15
Lexicon Pharmaceuticals stock hits 52-week low at $1
November 15
Lexicon Pharmaceuticals Inc (LXRX) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst ...
November 12
Lexicon Pharmaceuticals (LXRX) Reports Q3 Loss, Lags Revenue Estimates
November 12
Lexicon Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call Presentation
November 12
Lexicon Pharmaceuticals, Inc. (LXRX) Q3 2024 Earnings Call Transcript
November 12
Lexicon Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
November 12
Lexicon Pharmaceuticals to Participate in the Jefferies London Global Healthcare Conference
November 5
Lexicon Pharmaceuticals to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 12, 2024
November 4
Lexicon Pharmaceuticals Gets Negative FDA Panel Vote for Zynquista -- Update
October 31
Lexicon Pharmaceuticals Gets Negative FDA Panel Vote for Zynquista
October 31
Lexicon Pharmaceuticals Halted All Day as FDA Panel Reviews Zynquista
October 31
Needham & Company LLC Reaffirms "Hold" Rating for Lexicon Pharmaceuticals (NASDAQ:LXRX)
October 30
Buy Rating on Lexicon Pharmaceuticals Amidst FDA Concerns and Strategic Initiatives for Sotagliflozin
October 29
Optimistic Buy Rating for Lexicon Pharmaceuticals Due to Positive Outlook on Sotagliflozin’s FDA Review
October 29
Needham Sticks to Their Hold Rating for Lexicon Pharmaceuticals (LXRX)
October 29

Month over Month

Est. daily news mentions.

Oct 2024 0
Sep 2024 0
Aug 2024 0
Jul 2024 0
Jun 2024 0

How often is Lexicon Pharmaceuticals mentioned in the news?

Lexicon Pharmaceuticals was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Lexicon Pharmaceuticals performing compared to its industry peers?

Lexicon Pharmaceuticals underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Lexicon Pharmaceuticals in the last month?

There has been no significant change in the number of news mentions for Lexicon Pharmaceuticals' compared to the last month.

Why is it important to track news mentions for Lexicon Pharmaceuticals?

By monitoring mentions in the news for Lexicon Pharmaceuticals, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Lexicon Pharmaceuticals, ultimately improving their investment strategies.

Sign up and get more insights on Lexicon Pharmaceuticals.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact